Furthermore, TNF-α treatment increased the expression of genes encoding various proinflammatory cytokines such as IL-6, IL-8, IL-1β, and IL-17C, involved in the progression of inflammatory bowel disease. Here, IL17C is linked to inflammatory bowel disease.